Your Article Summary
See Latest ArticlesPrognostic factors predicting recurrence in borderline ovarian tumors
Gynecologic Oncology, 07/01/09
Wu TI et al. - Although BOT has an excellent prognosis, they are not exempted from a risk of recurrence. Stage II/III (or invasive implants), cystectomy and higher pre-operative serum CA-125 were independent variables predicting recurrence.
Related Articles
Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer
BMC Cancer, 11/04/09
Relevance Score: 69%
Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
BMC Cancer, 10/21/09
Relevance Score: 69%
Beta3-Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer
American Journal of Pathology, 10/06/09
Relevance Score: 69%
Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma
Human Pathology, 11/12/09
Relevance Score: 68%
Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions
American Journal of Obstetrics and Gynecology, 10/01/09
Relevance Score: 68%
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Papillary squamous intraepithelial lesions of the uterine cervix: human papillomavirus-dependent changes in cell cycle expression and cytologic features
Human Pathology, 12/07/09
Clinical management of uterine sarcomas
The Lancet Oncology, 12/07/09
Endometriosis: associations with menopause, hormone replacement therapy and cancer
Menopause International, 12/07/09